<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01941342</url>
  </required_header>
  <id_info>
    <org_study_id>NDR-2014-02</org_study_id>
    <nct_id>NCT01941342</nct_id>
  </id_info>
  <brief_title>Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy</brief_title>
  <official_title>Evaluation of Preoperative Biliary Drainage on Outcome of Pancreatoduodenectomy: A Multicenter Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of preoperative biliary drainage (PBD)&#xD;
      which is performed prior to pancreatoduodenectomy candidates with obstructive jaundice by&#xD;
      observing the prevalence of drainage and surgery related complications, hospital stay,&#xD;
      medical cost and life quality compared to surgery alone. It is anticipated that PBD can&#xD;
      reduce the prevalence of complications and improve the outcome of pancreatoduodenectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive jaundice is a common symptom in patients with pancreatic head cancer or&#xD;
      peri-ampullary cancer. It is regarded that proper surgical resection is the only possible way&#xD;
      of radical cure for those patients without evidence of metastasis. Since high preoperative&#xD;
      bilirubin level is suggested to be a risk factor for pancreatoduodenectomy, preoperative&#xD;
      biliary drainage has been applied to clinical practice to improve the outcome of surgery.&#xD;
      However, results from previous studies have inconsistent results showing that PBD may have&#xD;
      adverse effect on patients by elevating the prevalence of complications. Since PBD is widely&#xD;
      performed worldwide, its value needs to be clarified. Thus the present study is designed to&#xD;
      systematically evaluate the value of PBD via recruiting participants who may most likely&#xD;
      benefit from PBD. It is anticipated that results from this study can present an instructive&#xD;
      conclusion on whether PBD should be performed prior to pancreatoduodenectomy as well as&#xD;
      reveal the preferable type of PBD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Infectious Complications</measure>
    <time_frame>up to 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hemorrhagic Complications</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver Function Evaluation</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Bile Leakage</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Pancreatic Leakage</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life Quality Score</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Digestive Function Recovery</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of Incision Complications</measure>
    <time_frame>up to 3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Pulmonary Infections</measure>
    <time_frame>up to 6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Pleural Effusion</measure>
    <time_frame>up to 6 months</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">274</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Periampullary Carcinoma</condition>
  <arm_group>
    <arm_group_label>Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Instant pancreatoduodenectomy within one week after diagnosis including: Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ENBD and Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consistent ENBD (Endoscopic Nasobiliary Drainage) for 3 weeks or drainage until bilirubin level decreases to 200μmol per liter or below then perform pancreatoduodenectomy including:&#xD;
Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EBD and Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consistent EBD (Endoscopic Biliary Drainage) for 3 weeks or drainage until bilirubin level decreases to 200μmol per liter or below then perform pancreatoduodenectomy including:&#xD;
Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PTCD and Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consistent PTCD (Percutaneous Transhepatic Cholangial Drainage) for 3 weeks or drainage until bilirubin level decreases to 200μmol per liter or below then perform pancreatoduodenectomy including:&#xD;
Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreatoduodenectomy</intervention_name>
    <arm_group_label>Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ENBD and Pancreatoduodenectomy</intervention_name>
    <arm_group_label>ENBD and Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBD and Pancreatoduodenectomy</intervention_name>
    <arm_group_label>EBD and Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PTCD and Pancreatoduodenectomy</intervention_name>
    <arm_group_label>PTCD and Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 to 70 years old&#xD;
&#xD;
          -  CT (Computed Tomography), CTA (Computed Tomographic Angiography), MRI (Magnetic&#xD;
             Resonance Imaging) or ultrasonic test suggested pancreatic head carcinoma or&#xD;
             periampullary carcinoma with obstructive jaundice&#xD;
&#xD;
          -  First routine test of serum bilirubin above 250μmol per liter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Distant metastasis in liver, lung or other sites&#xD;
&#xD;
          -  Invasion of local blood vessels (e.g. aorta, portal vein, postcava)&#xD;
&#xD;
          -  Poor physical condition, unable to tolerate anesthesia and surgery (e.g. severe&#xD;
             cardio-pulmonary diseases, blood coagulation disorders)&#xD;
&#xD;
          -  With cholangitis, active hepatitis or other diseases which should be excluded from&#xD;
             study according to the investigators&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huai-zhi Wang, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southwest Hospital, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huai-zhi Wang, M.D., Ph.D.</last_name>
    <phone>86-23-13996950719</phone>
    <email>whuaizhi@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institution of Hepatobiliary Surgery, Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Liang-yu Yin, M.D.</last_name>
      <phone>86-23-13937975651</phone>
      <email>liangyuyin1988@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Huai-zhi Wang, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>September 10, 2013</study_first_submitted>
  <study_first_submitted_qc>September 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2013</study_first_posted>
  <last_update_submitted>January 13, 2014</last_update_submitted>
  <last_update_submitted_qc>January 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Huai-zhi Wang</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Obstructive Jaundice</keyword>
  <keyword>Preoperative Biliary Drainage</keyword>
  <keyword>Pancreatoduodenectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

